nivolumab,bevacizumab
bms,roche
['nivo', 'sclc', 'melanoma', 'nsclc', 'pdl']
not easy to dethrone king lion of io alone in high pdl1
glass ceiling to break with io alone in nsclc
1)several combo io strategies in pd-l1 &gt;50% negative,promising with beva plus ici
2)in melanoma antilag3 plus nivo work
3)in nsclc not so exciting data w antilag3 #asco2022 
Medical Oncologist - Thoracic tumors. Personalized treatment approches @EORTC